MUC1 and cancer: MUC1 is a cancer-associated antigen that has been effective as a vaccine in preclinical animal models but showed limited immunogenicity and efficacy as a therapeutic vaccine in clinical trials in colon, breast, pancreas, prostate and lung cancer (8–12).